Results 11 to 20 of about 7,961,527 (324)
Effects of model tear proteins and topical ophthalmic formulations on evaporation inhibition and biophysical property of model tear lipid nanofilm in vitro [PDF]
JCIS Open, 2021 Hypothesis: Biophysical property and water evaporation retardation through a lipid nanofilm can be altered by model tear protein and topical ophthalmic formulation.
Meng C. Lin, Tatyana F. Svitova
doaj +2 more sources
Journal of Ocular Pharmacology and Therapeutics, 2014 Purpose: The benzalkonium chloride (BAK) content of tafluprost ophthalmic solution (Tapros®: tafluprost) has been reduced to balance corneal safety and preservative effectiveness (old formulation: 0.01%; new formulation: 0.001%). However, no reports have
T. Kumagami +9 more
semanticscholar +3 more sources
Computation of dioptric and magnification matrices in ophthalmic lenses [PDF]
Journal of the European Optical Society-Rapid Publications, 2014 The diopter power and magnification matrices characterize the first-order properties of ophthalmic lenses for different gaze directions. Therefore an efficient method to compute them is highly valuable in ophthalmic lens design and optical performance ...
Barbero S.
doaj +4 more sources
In Vitro Evaluation of Combined Commercialized Ophthalmic Solutions Against Acanthamoeba Strains [PDF]
Pathogens, 2019 Acanthamoeba is a free-living amoebae genus which is present worldwide in natural and artificial environments. These amoebae are clinically important as causative agents of diseases in humans and other animals such as a fatal encephalitis or a sight ...
María Reyes-Batlle +14 more
doaj +2 more sources
Ophthalmic regional blocks: management, challenges, and solutions
Local and Regional Anesthesia, 2015 Howard D Palte Department of Anesthesiology, Perioperative Medicine and Pain Management, Miller School of Medicine, University of Miami, Miami, FL, USA Abstract: In the past decade ophthalmic anesthesia has witnessed a major transformation.
Palte HD
doaj +2 more sources
Journal of Pharmaceutical Health Care and Sciences, 2023 Background Pharmaceutical companies do not sell formulations for all diseases; thus, healthcare workers have to treat some diseases by concocting in-hospital preparations.
Masakazu Ozaki +12 more
doaj +2 more sources
A Sorption Study between Ophthalmic Drugs and Multi Dose Eyedroppers in Simulated Use Conditions
Pharmaceutical Technology in Hospital Pharmacy, 2017 Preservative free ophthalmic formulations need to be packaged either as single doses, or using specially designed sterility preserving multidose eyedroppers.
Le Basle Yoann +2 more
doaj +2 more sources
Effects of viscoelastic ophthalmic solutions on cell cultures
Indian Journal of Ophthalmology, 1998 The development of mild but significant inflammation probably attributable to viscoelastic ophthalmic solutions in cataract surgery was recently brought to the notice of the authors, and hence a study of the effects of these solutions available in India,
Madhavan Hajib, Roy Sara
doaj +1 more source
Influence of container structures and content solutions on dispensing time of ophthalmic solutions
Clinical Ophthalmology, 2010 Keiji Yoshikawa1, Hiroshi Yamada21Yoshikawa Eye Clinic, Tokyo, Japan; 2Santen Pharmaceutical Co., Ltd., Osaka, JapanPurpose: To investigate the influence of container structures and content solutions on the time of dispensing from eye dropper bottles ...
Keiji Yoshikawa, Hiroshi Yamada
doaj +1 more source
Stability of extemporaneously prepared ophthalmic solutions for mydriasis.
American Journal of Health-System Pharmacy, 2018 Purpose Results of an evaluation of the physical and chemical stability of extemporaneously prepared adult and pediatric ophthalmic solutions containing combinations of phenylephrine, tropicamide, and cyclopentolate are reported.
Nicole A. Camp +4 more
semanticscholar +2 more sources